BIOVIE INC

BioVie Inc. (BIVI) shares fall 3.12 % to $1.24, dropping 22.98 % month‑to‑date. Learn its market cap, liquidity, and peer performance to gauge future prospects.

Biovie Inc. (BIVI) edges up 1.61% amid market volatility, trading at $1.28—a promising lift for a biotech focused on liver‑cirrhosis therapies.

Biovie Inc. (BIVI) dives 9.49% as weak clinical data and regulatory uncertainty erode its $10.3 M market cap – investors face a hard decision.